Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma

Ophthalmology

Volumn 112, Issue 2, 2005, Pages 267-271

  Aung, Tin ^a,b   Chan, Yiong Huak ^b   Chew, Paul T K ^b,c  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST;

ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GONIOSCOPY; HUMAN; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRABECULAR MESHWORK; VISUAL FIELD DEFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA, ANGLE-CLOSURE; GONIOSCOPY; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC; TIMOLOL; TRABECULAR MESHWORK;

EID: 13444263525     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.08.024     Document Type: Article

References (24)

1. N. Ziai, J.W. Dolan, R.D. Kacere, R.F. Brubaker The effects on aqueous dynamics of PhXA41, a new prostaglandin F2alpha analogue, after topical application in normal and ocular hypertensive human eyes Arch Ophthalmol 111 1993 1351 1358
2. Alm A, Villumsen J, Törnquist P, et al. Intraocular pressure-reducing effect of PhXA41 in subjects with increased eye pressure: a one-month study. Ophthalmology 1993;100:1312-6, discussion 1316-7.
3. S. Nagasubramanian, G.P. Sheth, R.A. Hitchings, J. Stjernschantz Intraocular pressure-reducing effect of PhXA41 in ocular hypertension: comparison of dose regimens Ophthalmology 100 1993 1305 1311
4. A. Alm, J. Stjernschantz Scandinavian Latanoprost Study Group Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol Ophthalmology 102 1995 1743 1752
5. C.B. Camras United States Latanoprost Study Group Comparison of latanoprost and timolol in subjects with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States Ophthalmology 103 1996 138 147
6. H.K. Mishima, K. Masuda, Y. Kitazawa A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension A 12-week study Arch Ophthalmol 114 1996 929 932
7. P. Watson, J. Stjernschantz Latanoprost Study Group A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension Ophthalmology 103 1996 126 137
8. C.B. Toris, C.B. Camras, M.E. Yablonski Effects of PhXA41, a new prostaglandin F2alpha analogue on aqueous humour dynamics in human eyes Ophthalmology 100 1993 1297 1304
9. P.J. Foster, J. Baasanhu, P.H. Alsbirk Glaucoma in Mongolia, a population-based survey in Hovsgol Province, Northern Mongolia Arch Ophthalmol 114 1996 1235 1241
10. P.J. Foster, F.T. Oen, D. Machin The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district Arch Ophthalmol 118 2000 1105 1111
11. L. Dandona, R. Dandona, P. Mandal Angle-closure glaucoma in an urban population in southern India The Andhra Pradesh Eye Disease Study Ophthalmology 107 2000 1710 1716
12. T. Aung, H.T. Wong, C.C. Yip Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in subjects with chronic angle closure glaucoma: a preliminary study Ophthalmology 107 2000 1178 1183
13. P.T. Hung, J.W. Hsieh, Y.F. Chen, T. Wei Efficacy of latanoprost as an adjunct to medical therapy for residual angle-closure glaucoma after iridectomy J Ocul Pharmacol Ther 16 2000 43 47
14. P.T. Chew, T. Aung, M.V. Aquino, P. Rojanapongpun EXACT Study Group Intraocular pressure-reducing effects and safety of latanoprost versus timolol in subjects with chronic angle-closure glaucoma Ophthalmology 111 2004 427 434
15. SPSS [computer program]. Version 11.5. Chicago: SPSS Inc.; 2002.
16. P.T. Hung, L.H. Chou Provocation and mechanism of angle-closure glaucoma after iridectomy Arch Ophthalmol 97 1979 1862 1864
17. R.F. Lowe Persistent symptoms after peripheral iridectomy for angle-closure glaucoma Aust N Z J Ophthalmol 15 1987 83 87
18. Z. Alsagoff, T. Aung, L.P. Ang, P.T. Chew Long-term clinical course of primary angle-closure glaucoma in an Asian population Ophthalmology 107 2000 2300 2304
19. M. Rosman, T. Aung, L.P. Ang Chronic angle-closure with glaucomatous damage: long-term clinical course in a North American population and comparison with an Asian population Ophthalmology 109 2002 2227 2231
20. R.N. Weinreb, K. Kashiwagi, F. Kashiwagi Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells Invest Ophthalmol Vis Sci 38 1997 2772 2780
21. J.D. Lindsey, K. Kashiwagi, F. Kashiwagi, R.N. Weinreb Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow Surv Ophthalmol 41 suppl 1997 S53 9
22. R.N. Weinreb, C.B. Toris, B.T. Gabelt Effects of prostaglandins on the aqueous humor outflow pathways Surv Ophthalmol 47 suppl 2002 S53 64
23. T. Sagara, D.D. Gaton, J.D. Lindsey Topical prostaglandin F2 alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway Arch Ophthalmol 117 1999 794 801
24. D.D. Gaton, T. Sagara, J.D. Lindsey Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment Arch Ophthalmol 119 2001 1165 1170